Milk allergy is a common phenomenon with a prevalence of around 2% in 2-year-old children. Avoidance itself is not sufficient to prevent allergic reactions as suggested by one study reporting an incidence of 40% allergic reactions during a 12-month period. Thirty-seven percent of reactions were moderate to severe [1]. Therefore feasible treatment options for milk allergy are needed. Milk oral immunotherapy (OIT) has been investigated for treatment of milk allergy [2]. Many OIT trials targeted serving-size amounts of food such as approximately 5- 16 g in milk, 2 g in egg and 0.8-7 g in peanut OIT trials. Initial enthusiasm over OIT to milk was tempered by allergic reactions (19% with anaphylactic reaction at least once) and by limited long-term responders (31%) [3]........
The prevalence of food hypersensitivity in the UK is still largely open to debate. Additionally its pathogenesis is also unclear although it is known that there are differing phenotypes.
Cumulative incidence of food hypersensitivity by 2 years of age was 5.0 %. The cumulative incidence for individual food allergens were hens’ egg 2.7 % (1.6–3.8); cows’ milk 2.4 % (1.4–3.5); peanut 0.7 % (0.1–1.3); soy 0.4 % (0.0–0.8); wheat 0.2 % (0.0–0.5) and 0.1 % (0.0–0.32) for fish. The cumulative incidence of IgE-mediated food allergy was 2.6 % with 2.1 % reacting to hens’ egg. For non-IgE-mediated food allergy the cumulative incidence was 2.4 % (cows’ milk 1.7 %). Predictors for any food hypersensitivity were wheeze, maternal atopy, increasing gestational age, age at first solid food introduction and mean healthy dietary pattern score. Predictors for IgE mediated allergy were eczema, rhinitis and healthy dietary pattern score whereas for non-IgE-mediated food allergy the predictors were dog in the home, healthy dietary pattern score, maternal consumption of probiotics during breastfeeding and age at first solid food introduction.
Conclusions
Just under half the infants with confirmed food hypersensitivity had no demonstrable IgE. In an exploratory analysis, risk factors for this phenotype of food hypersensitivity differed from those for IgE-mediated food allergy except for a healthy infant diet which was associated with less risk for both phenotypes.
by Christian Schwager, Skadi Kull, Susanne Krause, Frauke Schocker, Arnd Petersen, Wolf-Meinhard Becker, Uta Jappe Background Peanut allergy is one of the most severe class I food allergies with increasing prevalence.
2015 review of recent research and relevant data that can help put peanut and food allergies in context, with a look at medical facts and trends relating to regulation.
Peanut allergy is an IgE-mediated adverse reaction to a subset of proteins found in peanuts. Immunotherapy aims to desensitize allergic patients through repeated and escalating exposures for several months to years using extracts or flours.
This consensus communication focuses on new data that support introducing peanuts early in infants, and it aims to assist with decisions about introduction; it can be used for guidance while formal guidelines are being developed.
US money keeps flowing into Europe's biotechs. As the race for the peanut allergy market heats up, NASDAQ listed French biotech DBV has announced the successful closing of US$281m (€256m) share offering for its allergy products.
The European Academy of Allergy and Clinical Immunology (EAACI) recently held its 2015 Annual Congress in Barcelona, Spain. FARE CEO Dr. James R. Baker, Jr. and FARE SVP of Research and Operations ...
The FDA granted breakthrough therapy designation to Viaskin Peanut, an epicutaneous delivery system, for the treatment of children aged 6 to 11 years with peanut allergy, according to a manufacturer’s press release.The Viaskin Peanut (DBV Technologies)...
French biopharmaceutical company DBV Technologies moves closer to bringing its peanut allergy patch to market, receiving Breakthrough Therapy Designation from the U.S. Food and Drug Administration as it prepares to launch its Phase 3 trial.
From BioPortfolio: Epicutaneous Immunotherapy (EPIT) introduces new way to treat peanut allergies Houston, TX (PRWEB) February 22, 2015 A team of researchers unveiled the results ...
To get content containing either thought or leadership enter:
To get content containing both thought and leadership enter:
To get content containing the expression thought leadership enter:
You can enter several keywords and you can refine them whenever you want. Our suggestion engine uses more signals but entering a few keywords here will rapidly give you great content to curate.